Patent ID: 8206296
Filing Date: 2012-06-26
Classification: A61B,A61M,G16H

Abstract:
1. A method, comprising: receiving, at a medical device, data associated with monitored glucose related levels measured by a glucose sensor for a first predetermined time period substantially in real time, the medical device having a processor unit; retrieving, using the processor unit, one or more therapy profiles associated with the monitored glucose related levels; determining, using the processor unit, a rate of change of the monitored glucose related levels for the first predetermined time period; extrapolating, using the processor unit, a projected glucose related level based on the monitored glucose related levels and the determined rate of change of the monitored glucose related levels; comparing, using the processor unit, the projected glucose related level with a corresponding -monitored glucose related level; confirming, using the processor unit, the monitored glucose related levels within a second predetermined time period after insulin therapy initiation, based at least in part on the comparison of the projected glucose related level with the corresponding monitored glucose related level, to determine whether the insulin therapy is having an intended therapeutic effect; generating, using the processor unit, one or more modifications to the retrieved one or more therapy profiles based on the data associated with the monitored glucose related levels, and updating, using the processor unit, an insulin sensitivity factor on an ongoing basis based at least in part on the comparison of the projected glucose related level with the corresponding monitored glucose related level.